Theophylline toxicity

Revision as of 22:34, 15 November 2018 by Mholtz (talk | contribs)

See theophylline for general drug information.

Background

  • Primarily used as a bronchodilator, however rarely used now due to better available options
  • Also studied for treatment of Acute Mountain Sickness and Contrast-Induced Nephropathy
  • PO available as elixer and capsule (12 or 24-hour extended release)
  • IV as aminophylline (shorter acting than PO)
  • Mechanism of action[1]:
    • Release of endogenous catecholamines → β2 agonism → bronchodilation
    • PDE inhibition → increases cAMP
    • Adenosine antagonist

Clinical Features

Differential Diagnosis

Evaluation

  • Theophylline level
  • ECG
  • Metabolic panel
  • Lactic acid level
  • CK

Management

Disposition

Immediate release

  • Home after 6 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

Sustained release

  • Home after 12 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

See Also

External Links

References

  1. Fisher, J., & Graudins, A. (2015). Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 11(3), 359-63.